Solution
Industries
Resources
About
Beacon Search

Synthetic Biology: Emerging Global Markets

Report Code: BIO066A

Publish Date: Jun 2009

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global market for synthetic biology generated $233.8 million in 2008. This is expected to increase to $2.4 billion in 2013, for a compound annual growth rate (CAGR) of 59.8%.
  • The chemicals and energy segment has the largest share of the market, worth $80.6 million in 2008. This should reach $1.6 billion in 2013, for a CAGR of 81.6%.
  • The biotechnology and pharmaceuticals segment is the second-largest market segment, worth 80.3 million in 2008. This segment is projected to increase at a CAGR of 49.2% to reach $594 million in 2013.

INTRODUCTION 

STUDY GOALS AND OBJECTIVES
 
BCC’s goal for this study is to determine the specific applications and forecast global market demand for synthetic biology products over a 5-year period from 2008 to 2013. Our particular interest is to characterize and quantify the synthetic biology products market potential by technology and end-use market segments. We also analyze the synthetic biology industry structure, competitors, and intellectual property landscape.
 
Synthetic biology products reviewed in this report include enabling technologies, biologic components, integrated systems, and enabled products.
 
Our key objective is to present a comprehensive analysis of the emerging synthetic biology industry, with an emphasis on products and technologies that are commercially important in the 2008 to 2013 time period. Market segments with rapid growth rates are highlighted. This analysis provides a quantitative basis and market context for companies to make strategic choices about participation in the synthetic biology industry. The study will be particularly useful to companies supplying synthetic genes, oligonucleotides, DNA sequencing instruments, biofuels, specialty chemicals, pharmaceuticals, vaccines, microfluidics, and life sciences tools.
 
REASONS FOR DOING THE STUDY
 
Synthetic biology is a rapidly emerging biotechnology discipline with a wide range of applications. Despite its emerging status, synthetic biology provides a significant number of near-term commercial opportunities, and the list of new products and applications is continuously growing. These applications include specialty chemicals, enzymes, synthetic genes and other DNA parts, pharmaceuticals, biofuels, and chassis microorganisms.
 
It is important for companies in industries affected by the developments in synthetic biology to sort through the many potential applications to identify near-term commercial opportunities for product development focus. This report allows companies to prioritize product opportunities, establishing a solid framework for strategic planning.
 
Synthetic biology encompasses a wide range of industries, including life science tools, biotechnology, pharmaceuticals, energy, and chemicals. Because of its wide scope, synthetic biology will play an important role in the future of the industrial economy of the early 21st century.
 
Ongoing advances in enabling technologies, such as microfluidics, DNA synthesis, DNA sequencing, and bioinformatics, as well as a need for renewable feedstocks, are driving the growth of synthetic biology. Rapid developments in these multidisciplinary fields promise to advance the synthetic biology industry and create unique market opportunities. This report analyzes these trends and their impact on the future markets for synthetic biology products.
 
Based on these market and technology dynamics, it is especially timely to examine the future synthetic biology markets.
 
INTENDED AUDIENCE
 
We have compiled a study of existing and future synthetic biology products and technologies that will be commercially important in the main end-user segments of life science research, pharmaceuticals, energy, and chemicals.
 
We present markets by end-use segment (R&D, biotech/pharmaceuticals, energy and chemicals) and by technology (enabling technologies, biologic parts, integrated systems, and enabled products). Key market segments include synthetic genes, chassis organisms, biofuels, specialty chemicals, and pharmaceuticals.
 
We present synthetic biology technologies, growth-driving forces, market applications, industry structure and competitive dynamics, companies and industry alliances, future market potential, and product sales forecasts for the period 2008 through 2013. We project the future use of synthetic biology products in the main end-user segments and by technology.
 
This report will be of particular interest to pharmaceuticals, chemicals, enzymes, energy, biotechnology, and nanobiotechnology companies, as well as suppliers of genomics tools, DNA synthesis, and DNA sequencing companies. It will also be of high interest to professionals within regulatory agencies to understand the scope and pace of synthetic biology technologies as they reach the market.
 
SCOPE OF REPORT
 
The study scope includes the synthetic biology products (synthetic genes, other DNA parts, chassis organisms, synthetic cells), enabling technologies (DNA sequencing, oligonucleotides, bioinformatics), and enabled technologies (biofuels, specialty chemicals, pharmaceuticals) that are already commercial or forecast to be commercialized within the next 5 years.
 
We analyze key synthetic biology technologies and products to determine present and future market status, and forecasted growth from 2008 through 2013. We also discuss strategic alliances, industry structures, competitive dynamics, patenting situation, and market-driving forces.
 
BCC examines the synthetic biology industry by market segment, including suppliers of synthetic genes, enzymes, pharmaceutical companies, bioenergy suppliers, and specialty chemicals. The role of key strategic alliances from 2006 through 2009 is discussed. Emerging markets including synthetic genes, synthetic biology-enabled drugs and vaccines, chassis organisms, and metabolically engineered factories for producing synthetic fuels and specialty chemicals are analyzed, and the main companies in these fields are highlighted.
 
METHODOLOGY
 
BCC surveys key users and producers in each of the end-user market segments and technology fields that will be commercially important during the next 5 years. Discussions with industry thought leaders, as well as secondary market research was performed.
 
Based on our analysis, we project the future applications of synthetic biology technologies in the major end-user market segments and by technology type, and forecast sales revenues for 2008 through 2013.
 
INFORMATION SOURCES
 
BCC surveyed leading synthetic biology, biotechnology, pharmaceutical, chemical, and energy companies to obtain data for this study. Included were life science research tools, drug, biotechnology, DNA synthesis and sequencing, and microfluidics firms, as well as leading life science research institutions. We also obtained inputs from leading academic and industry thought leaders. Data from secondary sources included industry, trade, and government publications.
 
ANALYST CREDENTIALS
 
The author, John Bergin, has written previous BCC biotechnology reports entitled Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics; Global Biochip Markets: Microarrays and Lab-on-a-chip; RNA Interference in the Post-Genomics Era: Markets and Technologies; DNA Sequencing: Emerging Technologies and Markets; and Biologic Imaging Reagent: Future Technologies and Markets. Mr. Bergin has held business development, sales, and marketing positions with a Fortune 500 advanced materials company as well as executive management positions with an emerging nanotechnology company. Mr. Bergin holds the following degrees: B.S. Chemistry, M.S. Biotechnology, and Master of Business Administration.
 
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:  
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers 
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Synthetic Biology: Emerging Global Markets245Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW10Free
Chapter- 4: SYNTHETIC BIOLOGY TECHNOLOGIES50Free
Chapter- 5: SYNTHETIC BIOLOGY APPLICATIONS 21Free
Chapter- 6: SYNTHETIC BIOLOGY INDUSTRY43Free
Chapter- 7: SYNTHETIC BIOLOGY MARKETS35Free
Chapter- 8: PATENT STATUS13Free
Chapter- 9: C. CRAMER & CO. GMBH66Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 100

  • Summary Table: GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY INDUSTRY, THROUGH 2013
  • Table 1: SCOPE OF THIS REPORT
  • Table 2: SYNTHETIC BIOLOGY GROWTH DRIVING FORCES
  • Table 3: GLOBAL VALUE OF SYNTHETIC BIOLOGY MARKET BY END USER, THROUGH 2013
  • Table 4: GLOBAL VALUE OF SYNTHETIC BIOLOGY-ENABLED ENERGY MARKET BY FUEL TYPE, THROUGH 2013
  • Table 5: SYNTHETIC BIOLOGY PRODUCTS AND TECHNOLOGY LIFE CYCLE STAGE
  • Table 6: SYNTHETIC BIOLOGY KEY COMPETITORS BY MARKET FOCUS
  • Table 7: SYNTHETIC BIOLOGY DEFINITIONS
  • Table 8: SYNTHETIC BIOLOGY HISTORY
  • Table 9: PARADIGM SHIFT OF BIOLOGY
  • Table 10: GENETIC ENGINEERING AND SYNTHETIC BIOLOGY COMPARED
Sample Report

Recent Reports

Biological Therapies for Cancer: Technologies and Global Markets

Published - Nov 2025 | Publisher - BCC Publishing | Code - BIO048E

The global biological therapies market for cancer is expected to grow from $157 billion in 2025 and is projected to reach $225 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2025 to 2030.

Cell Therapy Processing: Global Markets and Technologies

Published - Oct 2025 | Publisher - BCC Publishing | Code - BIO160B

The global market for cell therapy processing is estimated to grow from $2.7 billion in 2025 to reach $7.1 billion by 2030, at a compound annual growth rate (CAGR) 21.4% from 2025 to 2030.

Fusion Proteins: Global Market

Published - Oct 2025 | Publisher - BCC Publishing | Code - BIO274A

The global market for fusion proteins is expected to grow from $36.3 billion in 2025 to reach $64.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2030.

Separation Systems for Commercial Biotechnology

Published - Oct 2025 | Publisher - BCC Publishing | Code - BIO011H

The global market for bioseparation systems is expected to grow from $32.5 billion in 2025 and is projected to reach $45.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2025 to 2030.

Biomarker Deals: Terms Value and Trends 2019-2025

Published - Sep 2025 | Publisher - BCC Publishing | Code - BIO169B

This report provides an analysis of strategic transactions encompassing licensing, acquisitions and collaborations in the global biomarker market. It focuses on deals executed between 2019 and 2025, providing a retrospective assessment of deal-making activity to identify emerging trends, investment behaviors and strategic priorities in the biomarker landscape.

Top Trending Reports

Global Data Center Market

Published - Jul 2025 | Publisher - BCC Publishing | Code - IFT320A

The global market for data centers is expected to grow from $418.2 billion in 2025 and is projected to reach $691.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2025 to 2030.

Global Viral Vector Manufacturing Markets and Technologies Through 2030

Published - Sep 2025 | Publisher - BCC Publishing | Code - PHM172B

The global market for viral vector manufacturing is expected to grow from $6.3 billion in 2025 and is projected to reach $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 24.6% during the forecast period of 2025 to 2030.

Separation Systems for Commercial Biotechnology

Published - Oct 2025 | Publisher - BCC Publishing | Code - BIO011H

The global market for bioseparation systems is expected to grow from $32.5 billion in 2025 and is projected to reach $45.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2025 to 2030.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

Fusion Proteins: Global Market

Published - Oct 2025 | Publisher - BCC Publishing | Code - BIO274A

The global market for fusion proteins is expected to grow from $36.3 billion in 2025 to reach $64.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.3% from 2025 to 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Synthetic Biology: Emerging Global Markets
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2025 BCC Research
Privacy Policy |Site Map|Terms & Conditions
AI Sentiment